PATENT CLAIM ANALYSIS

Application Number: 15767221
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-03
Patent Classification: ["530", "397000"]

Abstract:
The present invention relates in general to a nucleic acid encoding human granulocyte-colony stimulating factor (G-CSF), wherein the first leucine residue occurring on the N-terminal end of the encoded G-CSF is encoded by a codon other than the CTG/CUG codon, and wherein the nucleic acid does neither comprise the nucleic acid sequence according to SEQ ID NO: 1, nor according to SEQ ID NO: 2, nor according to SEQ ID NO: 3, nor according to SEQ ID NO: 4. The present invention also relates to a nucleic acid 100% complementary to the aforementioned nucleic acid, as well as to vectors and host cells comprising the aforementioned nucleic acids. Finally, the present invention relates to methods for producing human G-CSF using these nucleic acids, vectors and/or host cells and resulting G-CSF compositions.

Claim (Index 9):
The host cell according to  claim 8 , wherein the host cell is a bacterial cell.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 91.0
- Lexical Diversity: 2.0411
- Patent Class: 530.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['11722527', '12492371', '12492387', '10651395', '10632695']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6590007720772043
- 35 USC 102 Novelty (BERT): 0.518914890822462
- Combined Prediction Score: 0.6449921839517301
- Mean Citation Score: 242.148668
- Max Citation Score: 246.271
- Similarity Product: 143.5277592063546

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test